Internal Medicine, Endocrinology, Diabetes, & Metabolism · Millington, TN
NPI
1538126784
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
8081 US Highway 51 N
Millington, TN, 38053
Phone (901) 872-4799
Groups this clinician bills Medicare through
Medicare paid, 2024
$197K
8,343 services
Medicare patients, 2024
378
Average age 71
Drug cost, 2024
$2.2M
17,003 prescriptions
Company payments, 2025
$728
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abdullah Baig was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,724 times for 28 patients. In total Abdullah Baig billed 8,343 services in 96 codes, and Medicare paid $197K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,724 | 28 | $0.10 | $173 |
| 99213 Office E&M - Established | Office | 768 | 273 | $54.42 | $42K |
| 99214 Office E&M - Established | Office | 713 | 304 | $76.60 | $55K |
| 82962 Clinical Chemistry | Office | 530 | 170 | $3.19 | $1,689 |
| 81002 Clinical Chemistry | Office | 301 | 194 | $3.39 | $1,020 |
| 96372 Injection Administration | Office | 299 | 108 | $9.14 | $2,732 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 296 | 57 | $0.31 | $92.45 |
| 99212 Office E&M - Established | Office | 245 | 52 | $39.40 | $9,652 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 224 | 66 | $0.08 | $17.22 |
| 36415 Venipuncture Blood Collection | Office | 217 | 181 | $8.65 | $1,877 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 185 | 25 | $42.91 | $7,938 |
| 93000 Electrocardiogram | Office | 163 | 138 | $8.59 | $1,400 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 157 | 16 | $0.50 | $78.79 |
| 80053 Clinical Chemistry | Office | 126 | 122 | $10.35 | $1,304 |
| 85025 Blood Count | Office | 121 | 120 | $7.61 | $921 |
By year: 2022 $237K for 6,349 services; 2023 $277K for 10,040 services; 2024 $197K for 8,343 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 530 | 170 | $3.19 | $1,689 |
| 81002 Clinical Chemistry | 301 | 194 | $3.39 | $1,020 |
| 36415 Venipuncture Blood Collection | 217 | 181 | $8.65 | $1,877 |
| 80053 Clinical Chemistry | 126 | 122 | $10.35 | $1,304 |
| 85025 Blood Count | 121 | 120 | $7.61 | $921 |
| 80061 Clinical Chemistry | 116 | 115 | $13.12 | $1,522 |
| 84443 Clinical Chemistry | 109 | 109 | $16.46 | $1,794 |
| 87428 Infectious Agent Detection by DNA/RNA | 98 | 74 | $67.92 | $6,657 |
| 82550 Clinical Chemistry | 84 | 84 | $6.38 | $536 |
| 83036 Blood Count | 78 | 77 | $9.52 | $743 |
Medicare prescription drug claims, 2024
In 2024, the drug Abdullah Baig prescribed most often to Medicare patients was Amlodipine Besylate, with 813 prescriptions and refills. In total Abdullah Baig wrote 17,003 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 813 | 2,073 | 275 | $3,935 |
| Rosuvastatin Calcium Generic | 607 | 1,570 | 215 | $10K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 558 | 558 | 165 | $7,051 |
| Pantoprazole Sodium Generic | 463 | 1,031 | 157 | $5,294 |
| Potassium Chloride Generic | 397 | 843 | 142 | $9,715 |
| Atorvastatin Calcium Generic | 389 | 954 | 129 | $4,465 |
| Metoprolol Succinate Generic | 362 | 852 | 116 | $4,831 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 343 | 397 | 116 | $12K |
| Levothyroxine Sodium Generic | 335 | 697 | 92 | $2,454 |
| Mounjaro Tirzepatide | 320 | 379 | 67 | $391K |
| Ozempic Semaglutide | 249 | 297 | 63 | $270K |
| Losartan Potassium Generic | 244 | 608 | 83 | $2,806 |
| Furosemide Generic | 238 | 470 | 96 | $795 |
| Omeprazole Generic | 226 | 541 | 69 | $3,600 |
| Tizanidine Hcl Generic | 216 | 299 | 79 | $1,887 |
Brand drugs: 2,696 claims; generic drugs: 14,191 claims; opioid claims: 862.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abdullah Baig $728 ($728 in general payments such as food, travel and fees) from 16 companies. The largest payer was Novo Nordisk Inc with $247.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 16 | $247 |
| Lilly USA, LLC LLY | 6 | $95.73 |
| Fidia Pharma USA Inc. | 2 | $41.81 |
| Amgen Inc. AMGN | 2 | $37.26 |
| Abbott Laboratories ABT | 2 | $36.92 |
| Viatris Specialty LLC | 2 | $32.94 |
| Averitas Pharma Inc. | 1 | $31.88 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $31.1 |
| Baxter Healthcare BAX | 1 | $30.04 |
| Philips North America LLC PHG | 1 | $29.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.